Clinical Trials Directory

Trials / Unknown

UnknownNCT00375635

Removal of Protein Bound Uremic Toxins by Modified Plasma Separation and Adsorption Combined With Hemodialysis

Removal of Protein Bound Uremic Toxins in Chronic Hemodialysis Patients by Modified Plasma Separation and Adsorption Combined With Hemodialysis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10 (planned)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to examine removal of protein bound uremic substances by mFPSA in chronic hemodialysis patients. mFPSA is an extracorporal blood purification system developed for detoxification in acute liver failure by removal of protein bound as well as water soluble substances.

Detailed description

Measurements of uremic protein bound substances before and after mFPSA and a preceding routine hemodialysis session.

Conditions

Interventions

TypeNameDescription
PROCEDUREmFPSA treatment

Timeline

Start date
2006-03-01
Completion
2006-10-01
First posted
2006-09-13
Last updated
2006-09-13

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00375635. Inclusion in this directory is not an endorsement.

Removal of Protein Bound Uremic Toxins by Modified Plasma Separation and Adsorption Combined With Hemodialysis (NCT00375635) · Clinical Trials Directory